Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)
Clinical trial NCT00916630 · COMPLETED
Trial details
- NCT number
- NCT00916630
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2015-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.